Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.1%

2 terminated out of 22 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (13)
P 1 (2)
P 2 (2)
P 3 (3)

Trial Status

Completed6
Active Not Recruiting5
Unknown4
Recruiting3
Not Yet Recruiting2
Terminated2

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07164534Phase 3Not Yet RecruitingPrimary

A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

NCT03955185Not ApplicableActive Not RecruitingPrimary

Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer

NCT06560697Not ApplicableRecruitingPrimary

Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma

NCT03994055Not ApplicableCompleted

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

NCT04516616Phase 2Active Not RecruitingPrimary

Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer

NCT06878196Not ApplicableNot Yet RecruitingPrimary

ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer

NCT04061967Not ApplicableRecruiting

Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.

NCT05880485Phase 1Active Not RecruitingPrimary

Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer

NCT05869123Phase 1Active Not RecruitingPrimary

Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

NCT05682950Phase 2Active Not RecruitingPrimary

Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

NCT03308591Phase 3CompletedPrimary

Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients

NCT06439706Not ApplicableCompletedPrimary

HPV Self-sampling for Underscreened Latinas

NCT06598176Not ApplicableRecruitingPrimary

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

NCT05022511Not ApplicableCompleted

Three Birds With One Stone

NCT04679675Not ApplicableCompletedPrimary

Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial

NCT03100409Not ApplicableTerminatedPrimary

Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients

NCT04974424UnknownPrimary

Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV

NCT04114968UnknownPrimary

Offering Cervical Cancer Screening to Older Women

NCT03971032Not ApplicableUnknownPrimary

An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure

NCT03739944Phase 3UnknownPrimary

Different Surgical Approaches in Patients of Early-stage Cervical Cancer

Scroll to load more

Research Network

Activity Timeline